Hydroxychloroquine

surface glycoprotein ; Severe acute respiratory syndrome coronavirus 2







11 Article(s)
Download
PMID
Title
Pub. Year
#Total Relationships
1 35000060 Pharmacophore screening to identify natural origin compounds to target RNA-dependent RNA polymerase (RdRp) of SARS-CoV2. 2022 Jan 9 1
2 32696720 Antimalarial-agent artemisinin and derivatives portray more potent binding to Lys353 and Lys31-binding hotspots of SARS-CoV-2 spike protein than hydroxychloroquine: potential repurposing of artenimol for COVID-19. 2021 Oct 2
3 32770567 Epigallocatechin gallate and theaflavin gallate interaction in SARS-CoV-2 spike-protein central channel with reference to the hydroxychloroquine interaction: Bioinformatics and molecular docking study. 2021 Feb 2
4 33531790 Enhanced production of camptothecin by immobilized callus of Ophiorrhiza mungos and a bioinformatic insight into its potential antiviral effect against SARS-CoV-2. 2021 Mar 1
5 33535144 Analogue discovery of safer alternatives to HCQ and CQ drugs for SAR-CoV-2 by computational design. 2021 Mar 1
6 33679150 Comparison of clinically approved molecules on SARS-CoV-2 drug target proteins: a molecular docking study. 2021 1
7 34337036 Characterization of the Modulatory Effect of Hydroxychloroquine on ACE2 Activity: New Insights in relation to COVID-19. 2021 1
8 34396938 Computational study for identifying promising therapeutic agents of hydroxychloroquine analogues against SARS-CoV-2. 2021 Aug 16 1
9 32562764 Dual function of sialic acid in gastrointestinal SARS-CoV-2 infection. 2020 Oct 1
10 32920291 Chloroquine and hydroxychloroquine as ACE2 blockers to inhibit viropexis of 2019-nCoV Spike pseudotyped virus. 2020 Dec 1
11 32991900 Novel insights into the treatment of SARS-CoV-2 infection: An overview of current clinical trials. 2020 Dec 15 1